D.E. Shaw & Co
CNMD icon

D.E. Shaw & Co’s CONMED CNMD Stock Holding History

D.E. Shaw & Co’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,000
Closed -$2.22M – 4505
2022
Q4 		$2.22M Hold
25,000
– – ﹤0.01% 2859
2022
Q3 		$2M Buy
+25,000
New +$2.36M ﹤0.01% 3013
2019
Q1 		– Sell
-4,600
Closed -$295K – 3632
2018
Q4 		$295K Hold
4,600
– – ﹤0.01% 3354
2018
Q3 		$364K Buy
+4,600
New +$356K ﹤0.01% 3281

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

D.E. Shaw & Co's CNMD Position: Q2 2026 in Review

D.E. Shaw & Co increased its CONMED (CNMD) stake by 42% in Q2 2026, buying an estimated $730K and bringing the position to 68,134 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3103.

D.E. Shaw & Co first reported a position in CNMD in Q3 2013 and has held it in 36 quarters since. The position peaked at $15.7M in Q4 2014. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • D.E. Shaw & Co held 68,134 shares of CONMED worth $2.23M as of Q2 2026.
  • D.E. Shaw & Co bought 20,283 CONMED shares in Q2 2026, an estimated $730K.
  • CONMED made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #3103 holding.
  • D.E. Shaw & Co first reported a position in CONMED in Q3 2013 and has held it in 36 quarters since.
  • D.E. Shaw & Co's CONMED position peaked at $15.7M in Q4 2014.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.